Salivary inflammatory mediator profiling and correlation to clinical disease markers in asthma. - Wikidata - awgldk - TriplyDB

Salivary inflammatory mediator profiling and correlation to clinical disease markers in asthma.

Salivary inflammatory mediator profiling and correlation to clinical disease markers in asthma.

http://www.wikidata.org/entity/Q37444881

about

Potential Use of Salivary Markers for Longitudinal Monitoring of Inflammatory Immune Responses to Vaccination Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice Correlations of salivary biomarkers with clinical assessments in patients with cystic fibrosis.Whole-Genome Saliva and Blood DNA Methylation Profiling in Individuals with a Respiratory Allergy Elevated Salivary Alpha-Amylase Level, Association Between Depression and Disease Activity, and Stress as a Predictor of Disease Flare in Systemic Lupus Erythematosus: A Prospective Case-Control Study.Yogic breathing when compared to attention control reduces the levels of pro-inflammatory biomarkers in saliva: a pilot randomized controlled trial The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside.Serum biomarkers for allergy in children.Selected CC and CXC chemokines in children with atopic asthma.Asthma Biomarkers: Do They Bring Precision Medicine Closer to the Clinic?

P2860

Q26750472-BBAA6922-15D8-4699-BBE2-C996E722B6B0 Q33894887-68CDA2B5-59F7-4E95-8010-9BEBEC0AF647 Q35741301-348C3291-BFB4-499A-BF53-5CEE31795A2F Q35964832-7763632C-9280-42F3-A52C-8BC53EC27BB9 Q36009350-6AD46DC9-AC99-4EE2-9546-92DDEE77790D Q36107344-DFD4EA3E-B1A8-4099-8146-4C6646881546 Q38542576-B90C0A2E-C1E2-45E0-A129-1BEB295AF569 Q38945312-2F5B603F-9136-44FB-BC85-4F72D2F80C7E Q39697646-4706A90F-2EEC-46F4-94AA-88C523B48E30 Q42736759-27A603AF-CE0A-4678-AABA-8F02B84EA033

P2860

Salivary inflammatory mediator profiling and correlation to clinical disease markers in asthma.

http://www.wikidata.org/entity/Q37444881

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Salivary inflammatory mediator ...... cal disease markers in asthma.

@en

Salivary inflammatory mediator ...... cal disease markers in asthma.

@nl

type

label

Salivary inflammatory mediator ...... cal disease markers in asthma.

@en

Salivary inflammatory mediator ...... cal disease markers in asthma.

@nl

prefLabel

Salivary inflammatory mediator ...... cal disease markers in asthma.

@en

Salivary inflammatory mediator ...... cal disease markers in asthma.

@nl

P1433

Q37444881-773B648D-0DB1-4600-B1CA-BD0279952EC7

P1476

Q37444881-918AAD79-03DF-4159-9119-A66859C8B39F

P2093

Q37444881-11D93F6C-9D2B-4933-9EA6-98FFAFAE9E56

Q37444881-2D3E45ED-675E-4CFD-8E08-AE94A65D7040

Q37444881-4B230FDF-ECA1-433D-B507-1FDFCF63150B

Q37444881-5392A2C4-B910-4B3E-A368-6089DD51E1CD

Q37444881-7A36A1BD-D2A8-400C-9EF2-F65228ED23BA

Q37444881-8369A360-40A9-464E-9663-CF9903040259

Q37444881-A4D12B0B-1458-4385-A29A-A2B105C17E43

Q37444881-B87AECA6-0C8A-48AE-9784-BAD3E311EC91

Q37444881-BDF8969B-E28F-447D-A952-77CBA916DF79

P2860

Q37444881-017553F4-8435-4424-8956-4976D60B5C5D

Q37444881-0A0634A8-9A2F-471D-BE5F-21705E63C096

Q37444881-0F746822-734F-4E62-9E77-9E68D501E8A8

Q37444881-2E2CF57E-E3EC-4299-BD13-373FD6A579D3

Q37444881-3745F490-7557-4C0A-BE28-86D5949A0DC3

Q37444881-3EB30748-9A7F-4F32-BFD3-0FC69E2D02DA

Q37444881-40FA2BFC-B08F-4B44-B9B2-6CF336C8C171

Q37444881-4F4A0ADD-79B1-4253-9573-739A98DF5D58

Q37444881-52FA5560-AD79-487D-8CC4-36DD799ADBA7

Q37444881-5CAE4C40-BEC7-4E78-8DAA-391FD7765E2E

P304

Q37444881-FDC22597-4F1A-46B0-9F5D-AB7499696E05

P31

Q37444881-38F20B7E-B357-40D9-B9C6-EE44B961E80A

P356

Q37444881-AE6AAB69-7DC8-4837-BC16-9FF08C46C6BA

P407

Q37444881-00BC786D-01EA-49BE-933E-9B1D88DA7818

P433

Q37444881-6E298476-179C-489C-AFC6-CE5D92FCD117

P478

Q37444881-8A4E50D2-B578-427E-B7FD-900925460AFB

P577

Q37444881-8E4DCE7E-F6D1-4613-931C-8A204F84D397

P5875

Q37444881-F9D18CA7-5E63-4930-88BC-E8294B3BB35E

P698

Q37444881-9DF428A6-0649-4BCD-B76E-8780C3006A7D

P921

Q37444881-0A8FF196-DE8A-4420-B955-3E814E2FB204

Q37444881-FCAE7A5D-9EF0-4473-86EE-B71E273280F2

P932

Q37444881-DE99A019-A08A-464A-BF5F-079921ABBE86

P356

JOURNAL.PONE.0084449

P1433

P1476

Salivary inflammatory mediator ...... cal disease markers in asthma.

@en

P2093

David R Walt

http://www.w3.org/2001/XMLSchema#string

Diana M Delgado

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Matsui

http://www.w3.org/2001/XMLSchema#string

Frank G Oppenheim

http://www.w3.org/2001/XMLSchema#string

Frédéric F Little

http://www.w3.org/2001/XMLSchema#string

James A Feldman

http://www.w3.org/2001/XMLSchema#string

Patricia Mitchell

http://www.w3.org/2001/XMLSchema#string

Philip J Wexler

http://www.w3.org/2001/XMLSchema#string

Roger D Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial

A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy

IP-10 detection in urine is associated with lung diseases

Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease.

Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009.

Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals.

An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children.

Salivary biomarkers for detection of systemic diseases

Essential role of nitric oxide in VEGF-induced, asthma-like angiogenic, inflammatory, mucus, and physiologic responses in the lung.

Saliva/pathogen biomarker signatures and periodontal disease progression.

P304

e84449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0084449

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259653494

http://www.w3.org/2001/XMLSchema#string

P698

24409298

http://www.w3.org/2001/XMLSchema#string

P921

P932

3883659

http://www.w3.org/2001/XMLSchema#string